RenovoRx IncChange company Symbol lookupSelect an option...RNXT RenovoRx IncOCGN Ocugen IncNEGG Newegg Commerce IncPHX PHX Minerals IncIRT Independence Realty Trust IncRLAY Relay Therapeutics IncCVU CPI Aerostructures IncMA Mastercard IncWDBG Neuro-Hitech IncGLRY Inspire Faithward Mid Cap Momentum ETFGo
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing therapies for the local treatment of solid tumors and conducting a Phase III pancreatic cancer clinical trial for its lead product candidate RenovoGem. The Company’s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) utilizes chemotherapeutics. RenovoTAMP combines its patented delivery system, RenovoCath, with small molecule chemotherapeutic agents, which can be forced across the vessel wall using pressure, targeting these anti-cancer drugs locally to the solid tumors. Its first product candidate, RenovoGem, is a drug /device combination consisting of intra-arterial gemcitabine and RenovoCath. RenovoGem has developed for the treatment of two rare diseases: pancreatic cancer and cholangiocarcinoma (CCA). It has completed its Phase I/II and observational registry studies, with 20 and 25 patients respectively, in locally advanced pancreatic cancer (LAPC).
|
|
|
|
| |
- Prev Close
- 2.99
- Today's Open
- 3.00
- Day's Range
- 2.90-3.30
- Avg Vol (10-day)
- 23.9K
- Last (time)
- 4:00p ET 03/28/23
- Last (size)
- 4
- 52-Wk Range
1.50 - 5.75- LowHigh
- 52-Wk Range
% Above Low
The current share price compared to the 52-week low.
- 102.00%
- Historical Volatility
Historical Volatility
The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.
- 101.3%
- Market Cap
- 27.6M
- Shares Outstanding
- 9.1M
- EPS (TTM, GAAP)
EPS (TTM, GAAP)
GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- -1.31
- P/E Ratio (TTM, GAAP)
P/E Ratio (TTM, GAAP)
GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- --
- Annual Dividend/Yield
Annual Dividend/Yield
Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.
- No dividend
- Ex-dividend Date
- No dividend
- Dividend Pay Date
- No dividend
- Beta
Beta
The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.
- --
- % Held by Institutions
% Held by Institutions
Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.
- 12.97
- Short Interest(% of float 02/28/23)
Short Interest
The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.
- 0.12
Latest News
| March 08, 2023 | |
|---|---|
| 8:30 am ET | |
| BusinessWire | |
| March 02, 2023 | |
| 8:30 am ET | |
| BusinessWire | |
| March 01, 2023 | |
| 8:30 am ET | |
| BusinessWire | |
| January 25, 2023 | |
| 8:30 am ET | |
| BusinessWire | |
| January 18, 2023 | |
| 8:30 am ET | |
| BusinessWire | |
| January 05, 2023 | |
| 8:30 am ET | |
| BusinessWire | |
| Go to all current & historical news | |
Events
- 03/02/23
Q4 2022 RenovoRx Inc Earnings Release - Actual: -$0.23 - 11/14/22
Q3 2022 RenovoRx Inc Earnings Release - Actual: -$0.24 - 08/12/22
Q2 2022 RenovoRx Inc Earnings Release - Actual: -$0.29 - 05/13/22
Q1 2022 RenovoRx Inc Earnings Release - Actual: -$0.33 - 03/30/22
Q4 2021 RenovoRx Inc Earnings Release - Actual: -$0.12
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.